Literature DB >> 18187275

Susceptibility testing of tulathromycin: interpretative breakpoints and susceptibility of field isolates.

K S Godinho1.   

Abstract

In vitro susceptibility tests were conducted on bovine and porcine respiratory pathogens isolated from European countries during 2004-2006 for susceptibility to tulathromycin using the recommended methodologies for broth microdilution. The results were compared with data from a similar survey conducted prior to launch in 1998-2001 to monitor for any shift in susceptibility. The importance of maintaining the pH of the culture media within the range 7.2-7.4 was re-affirmed as a key factor in obtaining consistent minimum inhibitory concentration data. The use of recently established interpretative breakpoints would indicate that to date there has been no apparent decrease in susceptibility to tulathromycin since it became widely used across Europe.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18187275     DOI: 10.1016/j.vetmic.2007.11.033

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  12 in total

1.  Molecular basis of macrolide, triamilide, and lincosamide resistance in Pasteurella multocida from bovine respiratory disease.

Authors:  Kristina Kadlec; Geovana Brenner Michael; Michael T Sweeney; Elzbieta Brzuszkiewicz; Heiko Liesegang; Rolf Daniel; Jeffrey L Watts; Stefan Schwarz
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

2.  Methaphylactic effect of tulathromycin treatment on rumen fluid parameters in feedlot beef cattle.

Authors:  Enrico Fiore; Leonardo Armato; Massimo Morgante; Michele Muraro; Matteo Boso; Matteo Gianesella
Journal:  Can J Vet Res       Date:  2016-01       Impact factor: 1.310

3.  Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for Streptococcus suis Infection.

Authors:  Yu-Feng Zhou; Hui-Min Peng; Ming-Xiao Bu; Ya-Hong Liu; Jian Sun; Xiao-Ping Liao
Journal:  Front Pharmacol       Date:  2017-09-27       Impact factor: 5.810

4.  Antibiotic susceptibility testing of Mycoplasma hyopneumoniae field isolates from Central Europe for fifteen antibiotics by microbroth dilution method.

Authors:  Orsolya Felde; Zsuzsa Kreizinger; Kinga Mária Sulyok; Veronika Hrivnák; Krisztián Kiss; Ákos Jerzsele; Imre Biksi; Miklós Gyuranecz
Journal:  PLoS One       Date:  2018-12-11       Impact factor: 3.240

5.  Pharmacodynamics of antimicrobials against Mycoplasma mycoides mycoides small colony, the causative agent of contagious bovine pleuropneumonia.

Authors:  John D Mitchell; Quintin A McKellar; Declan J McKeever
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

6.  Susceptibility to tulathromycin in Mannheimia haemolytica isolated from feedlot cattle over a 3-year period.

Authors:  Trevor W Alexander; Shaun Cook; Cassidy L Klima; Ed Topp; Tim A McAllister
Journal:  Front Microbiol       Date:  2013-10-09       Impact factor: 5.640

Review 7.  Mycoplasma bovis: Mechanisms of Resistance and Trends in Antimicrobial Susceptibility.

Authors:  Inna Lysnyansky; Roger D Ayling
Journal:  Front Microbiol       Date:  2016-04-27       Impact factor: 5.640

8.  The pharmacokinetic-pharmacodynamic modeling and cut-off values of tildipirosin against Haemophilus parasuis.

Authors:  Zhixin Lei; Qianying Liu; Bing Yang; Saeed Ahmed; Jiyue Cao; Qigai He
Journal:  Oncotarget       Date:  2017-12-07

9.  Pharmacokinetics and Pharmacodynamics of Tildipirosin Against Pasteurella multocida in a Murine Lung Infection Model.

Authors:  Dongping Zeng; Meizhen Sun; Zhoumeng Lin; Miao Li; Ronette Gehring; Zhenling Zeng
Journal:  Front Microbiol       Date:  2018-05-18       Impact factor: 5.640

10.  Investigating Effects of Tulathromycin Metaphylaxis on the Fecal Resistome and Microbiome of Commercial Feedlot Cattle Early in the Feeding Period.

Authors:  Enrique Doster; Pablo Rovira; Noelle R Noyes; Brandy A Burgess; Xiang Yang; Margaret D Weinroth; Steven M Lakin; Christopher J Dean; Lyndsey Linke; Roberta Magnuson; Kenneth I Jones; Christina Boucher; Jamie Ruiz; Keith E Belk; Paul S Morley
Journal:  Front Microbiol       Date:  2018-07-30       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.